Health-related quality-of-life and treatment satisfaction of individuals with hemophilia A treated with turoctocog alfa pegol (N8-GP): a new recombinant extended half-life FVIII

Health-related quality-of-life and treatment satisfaction of individuals with hemophilia A treated with turoctocog alfa pegol (N8-GP): a new recombinant extended half-life FVIII

Susan Kearney,1,* Leslie J Raffini,2 Tan P Pham,3 Xin Ying Lee,4 Sylvia von Mackensen,5,* Andrea Landorph,6 Hideyuki Takedani,7 Johannes Oldenburg8 1Center for Bleeding and Clotting Disorders, Children’s Hospital Minnesota, Minneapolis, MN, USA; 2Division of Hematology, The Children&r...

Full description

Bibliographic Details
Main Authors: Kearney S, Raffini LJ, Pham TP, Lee XY, von Mackensen S, Landorph A, Takedani H, Oldenburg J
Format: Article
Language:English
Published: Dove Medical Press 2019-04-01
Series:Patient Preference and Adherence
Subjects:
Hemophilia A
turoctocog alfa pegol
Health-Related Quality of Life
children
adults
treatment satisfaction
Online Access:https://www.dovepress.com/health-related-quality-of-life-and-treatment-satisfaction-of-individua-peer-reviewed-article-PPA

Internet

https://www.dovepress.com/health-related-quality-of-life-and-treatment-satisfaction-of-individua-peer-reviewed-article-PPA

Similar Items